PUMA BIOTECHNOLOGY, INC. Dilutive Share Adjustment
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Dilutive Share Adjustment of 1.66 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2026-06-30 was 1.66M shares, a 272.71% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2025-09-30 was 590.44K shares, a 258.06% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2025-06-30 was 444.49K shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month as first filed | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month as first filed | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1.66M shares 10-Q · filed 2026-08-06 | 1.39M shares 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |||||
| 2025-09-30 | 590.44K shares 10-Q · filed 2025-11-06 | 517.46K shares derived: average of 2 quarters · filed 2026-08-06 | 453.37K shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 444.49K shares 10-Q · filed 2026-08-06 | 355.46K shares 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | 310.64K shares 10-Q · filed 2026-05-07 | |||||
| 2024-09-30 | 164.90K shares 10-Q · filed 2025-11-06 | 82.45K shares derived: average of 2 quarters · filed 2025-11-06 | 526.52K shares 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |||||
| 2023-09-30 | 298.90K shares 10-Q · filed 2024-11-07 | 370.51K shares derived: average of 2 quarters · filed 2024-11-07 | 420.08K shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 442.12K shares 10-Q · filed 2024-08-01 | 474.84K shares 10-Q · filed 2024-08-01 | ||||
| 2023-03-31 | 521.82K shares 10-Q · filed 2024-05-02 | |||||
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-02 | 149.91K shares derived: average of 2 quarters · filed 2023-11-02 | 174.25K shares 10-Q · filed 2023-11-02 | 175.00K shares 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | 299.81K shares 10-Q · filed 2023-08-03 | 300.00K shares 10-Q · filed 2022-08-04 | 248.36K shares 10-Q · filed 2023-08-03 | 248.00K shares 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-04 | |||||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-03 | 0.00 shares derived: average of 2 quarters · filed 2022-11-03 | 0.00 shares 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-04 | 569.00K shares 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 634.00K shares 10-Q · filed 2022-05-05 | |||||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-04 | 283.00K shares derived: average of 2 quarters · filed 2021-11-04 | 0.00 shares 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | 566.00K shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |